Archive | March, 2011

Reauthorizing the Combating Autism Act?

12 Mar

The Combating Autism Act (CAA) committed the US government to fund autism research. As part of this effort, the Interagency Autism Coordinating Committee (IACC) was re-authorized (it actually predated the CAA, having been established under the Children’s Health Act of 2000)

At the end of the last congress, a Combating Autism Reauthorization Act (CARA) was presented. It was a nice move by Sentator Dodd as he was retiring, but as you will read if you follow the link, that bill is dead:

This bill never became law. This bill was proposed in a previous session of Congress. Sessions of Congress last two years, and at the end of each session all proposed bills and resolutions that haven’t passed are cleared from the books. Members often reintroduce bills that did not come up for debate under a new number in the next session.

If you go to the Senate’s webpage and enter “autism” as a search term for current bills, you will get two. Neither is the re-authorization of the CAA. Similar results come from searching Thomas for autism.

Sometimes I think, I just can’t find it. But it really isn’t there. In their piece Urge Congress to Reintroduce the Combating Autism Reauthorization Act!, “The Child Health Site” is asking people to sign a petition to reintroduce CARA.

The text of the original CAA you will find the following (or similar) a number of times: Sunset.–This section shall not apply after September 30, 2011.

Authorization for funding will sunset this year. The IACC will sunset this year. That is, of course, unless a re-authorization occurs. I haven’t seen much from the national autism organizations calling for action on this. There is undoubtedly much going on behind the scenes, but it strikes this observer that perhaps something should have happened by now.

Funding Science in a Time of Austerity

12 Mar

Funding Science in a Time of Austerity is a blog post by Tom Insel, director of the National Institute of Mental Health (NIMH) in the US.

I’ve discussed many news stories of late which discuss special education in these tight fiscal times. Naturally research will be impacted as well. While the article by Tom Insel does not discuss autism specifically, it is worth a read. NIMH has not had a final appropriation from the government for this fiscal year (which started in Oct. 2010). And they are expecting cuts for fiscal year 2012.

Following is a post by Tom Insel, director of the NIMH:

C. S. Lewis once said that the “task of a modern educator is not to cut down jungles but to irrigate deserts.” The same might be said of an NIH institute today. But our ability to irrigate deserts may be compromised as we appear to be facing an austere funding future. As the Nation struggles to regain its economic footing, the final budgets for NIH in 2011 and 2012 remain uncertain. But there is little doubt that these will be tough years for NIMH funding.

Here is a quick synopsis. Following the doubling of the NIH budget from 1998-2003, NIMH has received budgets with sub-inflationary increases each year. By 2009, we had lost about 18 percent of our purchasing power relative to 2003, but through strategic cuts in awards, reductions in the out-years of multi-year grants, and elimination of programs, NIMH was able to maintain relatively stable funding throughout this period. By stable funding, I mean that we continued to support roughly 550 new research grants (R01 and R21-type grants) each year, representing at least 15 percent of proposals.

In 2009 and 2010, the American Recovery and Reinvestment Act (ARRA) brought a surge in funding to create jobs. With over $370M, NIMH was able to support several innovative projects, create or retain jobs, and fund some additional R01-type grants (for 2 years) on top of our regular appropriated budget. But this one-time surge from ARRA obscured the longer-term pattern of flat budgets that continued in 2009 and 2010 beneath the ARRA bubble. In 2010, the NIMH budget was 2.6 percent higher than 2009, still losing ground to inflation.

What about 2011? Although our budget year began October 1, 2010, we are still awaiting a final appropriation. Last week, Congress passed a continuing resolution until March 18, which means we will continue to operate under our 2010 budget rather than the President’s 2011 budget proposed last February. Prior to March 18th, Congress must vote either to extend the continuing resolution or to appropriate a budget for the remainder of the year. Both houses of Congress are concerned about the growing deficit and are committed to reining in spending, especially within the 12 percent of the budget labeled as “discretionary.” This will almost certainly mean a reduction in the NIH and NIMH budgets, but we do not know the extent of this reduction. The House voted for a $1.6B reduction below the 2010 NIH budget for 2011, including a 4.1 percent reduction (-$60M from 2010) for NIMH, but this budget still needs to be considered by the Senate.

In the absence of a final budget for this year and with expectations that we will likely see reductions in 2012, NIMH has been cautious about funding grants. We have a few principles that have guided us: prioritize research relevant to our strategic plan, support innovation, maximize the number of R01 grants, and protect early stage scientists. In support of these principles, we have reduced our intramural program, funded fewer centers, and reduced support of some large programs.

But even with these changes, the 2010 budget leaves us short in 2011. Partly because of the number of continuing grants and partly because of the increasing average cost of new awards, if we receive the full 2010 budget for 2011, we are projecting 481 new grants, representing roughly 10 percent of proposals. This would be the first time since 1999 that we would fund fewer than 500 new grants and would mark the lowest success rate in over 15 years. If the 2011 appropriation is 4.1 percent less than the 2010 budget, the actual number of new grants funded will likely be below 400.

Not surprisingly, this situation is creating anxiety in the scientific community. Basic scientists believe that the money has been shifted to translation. Clinical researchers say that funds are only going to basic science. But in fact, the Division of Neuroscience and Basic Behavioral Science, which was 27 percent of the total NIMH budget in 2005, was 29 percent in 2010 and will likely be close to this portion again in 2011.

Some have suggested that the funds are going to Centers or the intramural program instead of investigator-initiated R01 grants. But the percentage of R01s has only increased over the past decade.

A few scientists have suggested that the problem is a recent change in the review policy, allowing only a single re-submission. While this policy must seem catastrophic for someone who just missed the payline with a re-submitted grant, re-instating the “A2” would only delay funding for those within the payline. It may not increase the number of grants funded or the success rate.

For scientists, this may feel like a funding desert. During this relative drought, there may be many reasons for complaints. But the bottom line is that funds for new grants are the lowest we have seen in several years and the average costs of new grants is higher than ever ($419K in 2010 vs $313K in 2005). NIMH is committed to funding the highest impact science with the available funds. But as much as we would like to “irrigate the desert,” some outstanding science will, unfortunately, not get funded. And those projects selected for funding may receive less than optimal support.

What makes this desert especially difficult is that the scientific opportunities have never been better. We have unprecedented traction in the science necessary to make progress for helping people with mental illness. However, in this period of austerity, we will not at this time be able to fund some of the science that will make a difference for those in greatest need.

Mitochondrial Disease and Autism: Linked?

11 Mar

Mitochondrial disease and autism. I don’t read about it as much as during the peak of the Hannah Poling story, but it is a big topic. Emily Willingham at
Thinking Person’s Guide to Autism has put together an excellent post on the subject. Here’s the first paragraph:

Hannah Poling’s family entered the national spotlight when they revealed that Hannah’s autism-like symptoms may have been linked to a reaction to several childhood vaccines at once in combination with her mitochondrial dysfunction. Her case was not the first revelation of a possible mitochondrial disorder (MD)-autism spectrum disorder (ASD) link, but because of her ultimately successful vaccine injury suit, she became the avatar of the vaccines-cause-harm movement — which almost eclipsed the real scientific and therapeutic feature of her case: the mitochondria.

I’d love to do a wholesale copy of the post, but that’s hardly fair now, is it? So, I’ll send you all to the Thinking Person’s Guide to Autism and Mitochondrial Disease and Autism: Linked?

Breaking news: Big green hairy monster to attend IMFAR 2011

11 Mar

This year I will be attending IMFAR. I am extremely grateful for the Autism Science Foundation for providing financial support to make this possible.

Last year, D’oC went to IMFAR and blogged about his experiences here on LeftBrainRightBrain. Here are his posts from then:

Blogging IMFAR: Wrap-Up Notes
Blogging IMFAR: Meet Roy Richard Grinker
Blogging IMFAR: Exceprts Of An Interview With David Mandell, ScD
Blogging IMFAR: Autism And Divorce Debunked, Among Others
Blogging IMFAR: Opening Press Conference and GFCF Diet Trial Results

People attending should look for the following character in the audience:

Vaccinated Children Not at Higher Risk of Infections or Allergic Diseases, Study Suggests

10 Mar

Seems German science has asked and answered the question everyone who believes vaccines damage the immune system wanted answering:

Do vaccinations put too much strain on or weaken children’s immune systems? Roma Schmitz and her colleagues from the Robert Koch Institute investigate exactly this research question in the current issue of Deutsches Ärzteblatt International.

Their data are based on the results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).

In their study, the authors compare the occurrence of infections and allergies in vaccinated and unvaccinated children and adolescents. These include bronchitis, eczema, colds, and gastrointestinal infections.

The evaluation showed that unvaccinated children and adolescents differ from their vaccinated peers merely in terms of the frequency of vaccine preventable diseases. These include pertussis, mumps, or measles. As expected, the risk of contracting these diseases is substantially lower in vaccinated children and adolescents.

Daytime sleep patterns in preschool children with autism, developmental delay, and typical development

10 Mar

I’ve read a lot of discussions of sleep issues with young autistic children. A recent paper from U.C. Davis discusses this, but from a slightly different angle than I’ve seen before.

The sleep paper I find interesting in that it focuses on daytime sleep patterns: napping. My recollection is that most discussions focus on night time sleeping–as in, “my kid doesn’t sleep!”. It is interesting to think that daytime sleep patterns might be different as well:

Daytime sleep patterns in preschool children with autism, developmental delay, and typical development.

Schwichtenberg AJ, Iosif AM, Goodlin-Jones B, Tang K, Anders T.

University of California, Davis.
Abstract

Abstract The present study examined daytime sleep patterns in 3 groups of preschool-aged children: children with autism, children with developmental delay, and children who were developing typically. Sleep was assessed in 194 children via actigraphy and parent-report sleep diaries for 7 consecutive days on 3 separate occasions over 6 months. Children with autism napped less often and for shorter periods of time than children with developmental disability, with whom they were matched on chronologic age. Children with developmental disabilities napped more like children in the typically developing group, who were, on average, 6 months younger. Each group displayed an expected shift in daytime sleep as more children matured out of their naps.

Autism Science Foundation announces IMFAR stakeholder travel grant recipients

10 Mar

The Autism Science Foundation has announced the recipients of this year’s stakeholder travel grants for IMFAR.

The press release is below:

AUTISM SCIENCE FOUNDATION ANNOUNCES
IMFAR STAKEHOLDER TRAVEL GRANT RECIPIENTS

IMFAR Stakeholder Travel Awards will Support Parents, Individuals with Autism, Teachers & Students

(March 10, 2011—New York, NY)–The Autism Science Foundation, a not for profit organization dedicated to supporting and funding autism research, today announced the recipients of its IMFAR Stakeholder Travel grants. ASF will make 11 awards of up to $1000 to be used to cover expenses related to attending the International Meeting for Autism Research in San Diego in May 2011. After the conference, grant recipients will be expected to share what they’ve learned with families in their local communities and/or online.

This year’s recipients are:

Geraldine Bliss–Parent
Matthew Carey–Parent
Shannon Des Roches Rosa–Parent
Mark Fornefeld–Self Identified Individual with Autism
Abby Hare–Graduate Student
Erin Lopes–Parent
Molly McGrath–Self Identified Individual with Autism/MIT Media Lab
Brianna Miller–Special Ed Teacher, Newark Public Schools
Sharman Ober-Reynolds–Parent/Senior Research Coordinator, SARRC
Megan O’Boyle –Parent
Max Rolison–Undergraduate Student

IMFAR is an annual scientific meeting, convened each spring, to promote exchange and dissemination of the latest scientific findings in autism research and to stimulate research progress in understanding the nature, causes, and treatments for autism spectrum disorders. IMFAR is the annual meeting of the International Society for Autism Research (INSAR).

“We are thrilled to be able to give back directly to the autism community in a research-focused way”, said Alison Singer, President of the Autism Science Foundation. “We are confident that the award recipients will all do a great job of bringing critical new research information to their communities, improving the speed with which the latest data are shared with the broader autism community.”

The Autism Science Foundation is a 501(c)(3) public charity launched in 2009 whose mission is to support autism research by providing funding to those who conduct, facilitate, publicize and disseminate autism research. ASF also provides information about autism to the general public and serves to increase awareness of autism spectrum disorders and the needs of individuals and families affected by autism.

The International Society for Autism Research (INSAR) is a scientific and professional organization devoted to advancing knowledge about autism spectrum disorders. INSAR was created in 2001. The society runs the annual scientific meeting – the International Meeting for Autism Research (IMFAR) and publishes the research journal “Autism Research”.

Contact Info:

Julie Martin
Events and Media Manager
Autism Science Foundation
jmartin@autismsciencefoundation.org
419 Lafayette Street, 2nd floor
New York, NY 10003

Shrinking special ed counts in San Diego Unified

9 Mar

The On Special Education blog at Education Week has a piece up that intrigued me: Fewer Special Ed. Students? Or Fewer Identified?

On Special Education referred back to this story (Where Did the Kids with Disabilities Go?) on Voice of San Diego.org.

I’ve been reading a lot of stories about the high numbers of special education students around the country lately. San Diego Unified has the opposite trend:

“School district officials counted nearly 1,600 fewer special education students this December than three years ago. That adds up to a 9.5 percent drop over the same time that overall enrollment fell only 1 percent,” writes Emily Alpert.

I decided to take a quick look at the data for San Diego Unified. I’ll warn you here, I didn’t find a clear indication of what is going on:

Total Special education students:

2006: 17,015
2007: 16,849
2008: 16,450
2009: 16,124

A drop of 891 students (about 5%)

Compare this to the figures for San Diego County as a whole:

2006: 58,745
2009: 58,475

A drop of 270 students (0.5%). San Diego Unified, the district, is dropping about 10x faster than San Diego county.In other words, the rest of San Diego County actually went up by about 600 students while San Diego Unified went down.

For those wondering (this is an autism-focus blog, after all), the number of students in the “autism” category went up notably in that time for the district, from 848 to 1,275. This is the opposite trend as the Special Education numbers as a whole, and more consistent with what the rest of the state is seeing.

Back to the drop: So why are the number of special education students going down? Emily Alpert of Voice of San Diego wrote about why she chose this story:

Some of the biggest drops have been in the same kinds of disabilities that a Harvard researcher tagged as having disproportionate numbers of minority students.

I decided to take a look by category and by race/ethnicity. It isn’t so clear to me. There are big drops in multiple categories including:

Specific Learning Disability: 7,260 (2006) to 6,584 (2009)
Speech Language Impairment: 4,040 to 3,351
Mental Retardation: 1,058 to 936
Emotional Disturbance: 1,032 to 839.

How does this break down by racial/ethnic status?

Let’s look at Specific Learning Disability as an example. Checking the three largest racial/ethnic groups (African American, Hispanic, White). Between 2006 and 2009, there were drops the SLD counts for all three:

White: 25% drop
Hispanic: 1.3% drop
African American: 21% drop

All three groups are seeing drops in the SLD counts, but Hispanics much less so, percentage wise.

Checking Speech Language Impairment (SLI) between 2006 and 2009:

White: 22% drop
Hispanic: 15% drop
African American: 44% drop

Again, there are drops across all three of these (the largest) racial/ethnic groups in San Diego Unified. And, again, Hispanics have the lowest drop. In this case (SLI), African American’s have the largest drop, percentage wise.

I know this is not a clear result. But I think that applies to the comments made in the San Diego press as well. Emily Alpert asked: “Is the imbalance in disability rates among students of different races changing or are the numbers just dropping?” It looks like neither is a clear answer. I wish I had the time to look at this more deeply. Clearly something or somethings is/are going on in San Diego Unified.

Is the imbalance in disability rates among students of different races changing or are the numbers just dropping?

Year one of the iPad–and the super secret Leo project

8 Mar

Apple celebrated the 1 year anniversary of the iPad just recently. Why not, they made a ton of money off these things. iPads have had much discussion on the web as being beneficial for the disabled. Amongst the autism-parent bloggers, probably no one has carried that torch more than Shannon Des Roches Rosa, who writes on BlogHer. Squidalicious, and The Thinking Person’s Guide to Autism.

If you follow those blogs you know this already: Shannon, Leo and Iz were in the video that Apple produced for the Year One event. Leo in the Apple: iPad – Year One Video and My Son the Top-Secret Apple iPad Project.

Here’s the video. They start talking about autism at about

There is a lot of talk about the iPad and the iPod touch as educational tools, AAC devices and the like. I got pulled into the world nearly two years back with discussion of the benefits of the iPod touch, by one of my favorite commenters on this blog. I really like the way Shannon posed it though: a piece of independence.

Lack of Infection with XMRV or Other MLV-Related Viruses in Blood, Post-Mortem Brains and Paternal Gametes of Autistic Individuals.

7 Mar

Another paper has come out showing no link between XMRV (Xenotropic murine leukemia virus-related virus) and autism. A study last year (discussed on LBRB here) stated “These results imply that XMRV is not associated with autism.” In a study just released in the journal PLOS One, we see more evidence against such a link:

Lack of Infection with XMRV or Other MLV-Related Viruses in Blood, Post-Mortem Brains and Paternal Gametes of Autistic Individuals.

Lintas C, Guidi F, Manzi B, Mancini A, Curatolo P, Persico AM.

Laboratory of Molecular Psychiatry and Neurogenetics, University Campus Bio-Medico, Rome, Italy.
Abstract

BACKGROUND: Autistic spectrum disorder (ASD) is characterized by impaired language, communication and social skills, as well as by repetitive and stereotypic patterns of behavior. Many autistic subjects display a dysregulation of the immune system which is compatible with an unresolved viral infection with prenatal onset, potentially due to vertical viral transmission. Recently, the xenotropic murine leukemia virus-related virus (XMRV) has been implicated in chronic fatigue syndrome (CFS) and in prostate cancer by several, though not all studies.

METHODOLOGY/PRINCIPAL FINDINGS: We assessed whether XMRV or other murine leukemia virus (MLV)-related viruses are involved in autistic disorder. Using nested PCR targeted to gag genomic sequences, we screened DNA samples from: (i) peripheral blood of 102 ASD patients and 97 controls, (ii) post-mortem brain samples of 20 ASD patients and 17 sex- and age-matched controls, (iii) semen samples of 11 fathers of ASD children, 25 infertile individuals and 7 fertile controls. No XMRV gag DNA sequences were detected, whereas peripheral blood samples of 3/97 (3.1%) controls were positive for MLV. CONCLUSIONS|

SIGNIFICANCE: No MLV-related virus was detected in blood, brain, and semen samples of ASD patients or fathers. Hence infection with XMRV or other MLV-related viruses is unlikely to contribute to autism pathogenesis.

The study concludes quite simply:

Our results, combined with those reported by Sutherfield et al [14], render XMRV contributions to autism highly unlikely. Nonetheless we cannot exclude that MLV-related viruses may play a role in rare cases.

Note that “Sutherfield” is a typo. Should be Satterfield. The reference is to the paper in Molecular Autism which was the topic of the discussion from last year that I linked to in the introduction to this piece.